Gynecological surgical approach to a patient with Sneddon's syndrome

Öz

In this case report, the management of a patient with Sneddon’s syndrome who underwent laparoscopic hysterectomy for menometrorrhagia and multiple leiomyoma uteri is discussed. The clinical management of Sneddon’s syndrome is based on four distinct aspects: Neurological, hematological, dermatological, and psychiatric. Their analysis can be a valuable tool in the preoperative and postoperative monitoring of these patients.

Anahtar Kelimeler

• Sneddon’s syndrome
• menorrhagia
• laparoscopy

Kaynakça

1. 1. Zelger B, Sepp N, Stockhammer G, Dosch E, Hilty E, Ofner D. Sneddon’s syndome. A long-term follow-up of 21 Patients. Arch Dermatol. 1993;129(4):437-47.
2. 2. Abraheem A, Morcos BA. Sneddon’s Syndrome Unusual Features and Associations Eur J Gen Med. 2011;8(3):240-2.
3. 3. Geschwind DH, Fitz Patrick M, Mischel PS, Cummings JL. Sneddon’s syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence. Neurology. 1995;45(3 Pt 1):557-60.
4. 4. Jonas J, Kolble K, Volcker H. Central retinal occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophtal. 1986;102(1):37-9.
5. 5. Kalashnikova LA, Nasonov EL, Kushekbaeva LA. Anticardiolipin antibodies in Sneddon's syndrome. Neurology. 1990;40(3 Pt 1):464-7.
6. 6. Levine SR, Langer SL, Albers JW, Welch KMA. Sneddon's syndrome: an antiphospholipid antibody syndrome. Neurology. 1988;38(5):798-800.
7. 7. Manganelli P, Lisi R, Saginario A, Benoldi D. Sneddon's syndrome and primary antiphopholipid syndrome. A case report. J Am Acad Derm. 1988;26(2 Pt 2):309-11.
8. 8. Montalban J, Ordi J, Barquinero J, Vilardell M. Sneddon's syndrome and anticardiolipin antibodies (letter). Stroke. 1988;19(1):75-6.

9. 9. Moral A, Vidal J, Moreau I, D'Olhaberriague L, Montalbán J. Sneddon's syndrome with antiphospholipid antibodies and arteriopathy. Stroke. 1991;22(10):1327-8.
10. 10. Bolayir E, Yilmaz A, Kugu N, Erdogan H, Akyol M, Akyuz A. Sneddon’s syndrome: clinical and laboratory analysis of 10 cases. Acta Med Okayama. 2004;58(2):59-65.
11. 11. Rebollo M, Val JF, Garijo F, Quintana F, Berciano J. Livedo reticularis and Cerebrovascular lesions (Sneddon's syndrome). Brain. 1983;106(4):265-8.
12. 12. Weissenborn K, Lubach D, Schwabe C, Becker H. Sneddon's syndrome:Clinical course and outcome. J Neurol. 1989;236(1):34-7.
13. 13. Stockhammer G, Felber SR, Zelger B, Sepp N, Birbamer GG, Fritsch PO, Aichner FT. Sneddon's Syndrome: Diagnosis by Skin Biopsy and MRI in 17 Patients. Stroke. 1993;24(5):685-90.
14. 14. Valtchev V, Simeonova V, Gospodinov D, Yordanova I, Dimitrova V, Pavlova V,et al. Sneddon’s syndrome. J of IMAB. 2008;14(1):72-5.
15. 15. Otoyama K, Katayama I, Suzuki Y, Tone T, Nishioka K, Nishiyama S. A case of Sneddon's syndrome with positive ANA and Anti-cardiolipin antibodies: Primary antiphospholipid syndrome J Dermatol. 1990;17(8):489-92.
16. 16. Wright RA, Kokmen E. Gradually progressive dementia without discrete Cerebrovascular events in a patient with Sneddon’s syndrome. Mayo Clin Proc. 1999;74(1):57-61.
17. 17. Burton JL. Livedo reticularis, porcelain-white scars and cerebral thromboses. Lancet. 1988;1(8597):1263-5.
18. 18. Yaman M, Gök S, Kulaç M, Değirmenci B, Albayrak R, Yılmaz Ö. Sneddon sendromu; Olgu sunumu ve literatürün gözden geçirilmesi. Tıp Araştırmaları Dergisi. 2007;5(1):49-51.
19. 19. Flöel A, Imai T, Lohmann H, Bethke F, Sunderkötter C, Droste DW. Therapy of Sneddon's syndrome. Eur Neurol. 2002;48(3):126-32.